FTSE 100 Poised to Extend Gains Despite AstraZeneca Vaccine Concerns

The UK benchmark FTSE 100 may shrug aside concerns regarding the AstraZeneca coronavirus vaccine and push to fresh post-crisis highs, on the back of swelling optimism as Britain progresses to the n…

from DailyFX – Market News https://bit.ly/3t103Os
via IFTTT

from WordPress https://bit.ly/3s0gfOL
via IFTTT

from Blogger https://bit.ly/31Tdzrq
via IFTTT

from WordPress https://bit.ly/3wB0wsT
via IFTTT

from Blogger https://bit.ly/3t2XE5E
via IFTTT